Royal Bank of Canada’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6770 |
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6567 |
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6528 |
|
2024
Q3 | $0 | Sell |
1
-9
| -90% | – | ﹤0.01% | 6681 |
|
2024
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 6864 |
|
2024
Q1 | $0 | Sell |
10
-1,333
| -99% | – | ﹤0.01% | 6785 |
|
2023
Q4 | $17K | Buy |
1,343
+1,322
| +6,295% | +$16.7K | ﹤0.01% | 5821 |
|
2023
Q3 | $0 | Sell |
21
-44
| -68% | – | ﹤0.01% | 6807 |
|
2023
Q2 | $1K | Buy |
+65
| New | +$1K | ﹤0.01% | 6574 |
|
2022
Q4 | – | Sell |
-17
| Closed | – | – | 6978 |
|
2022
Q3 | $0 | Buy |
+17
| New | – | ﹤0.01% | 7130 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 6598 |
|
2020
Q3 | – | Sell |
-4
| Closed | – | – | 6251 |
|
2020
Q2 | $0 | Sell |
4
-12
| -75% | – | ﹤0.01% | 6232 |
|
2020
Q1 | $1K | Sell |
16
-7
| -30% | -$438 | ﹤0.01% | 5951 |
|
2019
Q4 | $2K | Hold |
23
| – | – | ﹤0.01% | 5952 |
|
2019
Q3 | $2K | Buy |
23
+12
| +109% | +$1.04K | ﹤0.01% | 5627 |
|
2019
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 5747 |
|
2019
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 5630 |
|
2018
Q4 | $1K | Sell |
11
-1
| -8% | -$91 | ﹤0.01% | 5667 |
|
2018
Q3 | $2K | Buy |
+12
| New | +$2K | ﹤0.01% | 5911 |
|